Literature DB >> 1279982

Neurokinin3 receptor regulation of acetylcholine release from myenteric plexus.

W M Yau1, K G Mandel, J A Dorsett, M L Youther.   

Abstract

This study sought to characterize the action of neurokinin B (NKB) and senktide, a selective synthetic agonist for NK3 receptors, on the myenteric plexus of the guinea pig small intestine. Both peptides stimulated a dose-dependent release of [3H]-acetylcholine (ACh). The mean effective dose values were 1 x 10(-9) for NKB and 3 x 10(-11) M for senktide. The action of these two neurokinins was blocked by the removal of Ca2+ and was sensitive to tetrodotoxin. The release of [3H]ACh was antagonized by omega-conotoxin GVIA, implying the involvement of N-type voltage-sensitive calcium channels. Senktide-evoked ACh release was also insensitive to nifedipine or flunarizine but was blocked by diltiazem. Treatment with protein kinase C (PKC) inhibitors (H-7 and polymyxin B) or activators (12-tetradecanoylphorbol 13-acetate and SC-9) failed to alter the NK3 receptor-mediated ACh output. Our data did not support an action mediated via PKC upon the activation of NK3 receptors on myenteric cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279982     DOI: 10.1152/ajpgi.1992.263.5.G659

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine.

Authors:  J G De Man; B Y De Winter; H U De Schepper; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

2.  Tachykinins as mediators of slow EPSPs in guinea-pig gall-bladder ganglia: involvement of neurokinin-3 receptors.

Authors:  G M Mawe
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

3.  Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.

Authors:  E F Grady; P Baluk; S Böhm; P D Gamp; H Wong; D G Payan; J Ansel; A L Portbury; J B Furness; D M McDonald; N W Bunnett
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

4.  Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones.

Authors:  A C Myers; B J Undem
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

5.  Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2.

Authors:  K McConalogue; C U Corvera; P D Gamp; E F Grady; N W Bunnett
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

6.  Calcitonin gene-related peptide facilitates serotonin release from guinea-pig colonic mucosa via myenteric neurons and tachykinin NK2/NK3 receptors.

Authors:  Shu-Ichi Kojima; Shuichi Ueda; Masashi Ikeda; Yuichiro Kamikawa
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

7.  Analysis of contributions of acetylcholine and tachykinins to neuro-neuronal transmission in motility reflexes in the guinea-pig ileum.

Authors:  P J Johnson; J C Bornstein; S Y Yuan; J B Furness
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 8.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

9.  In vivo evidence for the involvement of tachykinin NK3 receptors in the hexamethonium-resistant inhibitory transmission in the rat colon.

Authors:  A Lecci; S Giuliani; M Tramontana; S Meini; R De Giorgio; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

10.  On the nature of the 5-HT receptor subtype inhibiting acetylcholine release in the guinea-pig ileum.

Authors:  M J Ramírez; J Del Río; E Cenarruzabeitia; B Lasheras
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.